INTRODUCTION
Bone is a dynamic tissue undergoing modeling during childhood and remodeling throughout adulthood (Harada and Rodan, 2003; Rodan and Martin, 2000) . These two processes, referred to hereafter as bone (re)modeling, are characterized by the succession of resorption of mineralized bone by osteoclasts and de novo formation by osteoblasts. Bone (re) modeling is regulated locally by cytokines produced by bone cells and systemically by hormones and neuropeptides (Harada and Rodan, 2003; Karsenty et al., 2009) . One of the most powerful hormonal regulations of bone (re)modeling is exerted by the sex steroid hormones that are necessary to maintain bone integrity (Khosla et al., 2001; Nakamura et al., 2007; Riggs et al., 1998) . The biological importance of this regulation is best exemplified by the fact that gonadal failure triggers bone loss and causes osteoporosis in postmenopausal women (Manolagas et al., 2002; Rodan and Martin, 2000) . To date, the study of the interplay between gonads and bone has focused on the mechanism whereby sex steroid hormones affect bone mass accrual (Manolagas et al., 2002; Nakamura et al., 2007) .
Based on physiological and clinical observations, we hypothesized 10 years ago that bone mass, energy metabolism, and reproduction might be coordinately regulated (Ducy et al., 2000) . Testing this hypothesis revealed that bone is an endocrine organ favoring whole-body glucose homeostasis and energy expenditure. These functions of bone are mediated by an osteoblast-specific secreted molecule, osteocalcin, that, when uncarboxylated, acts as a hormone favoring b cell proliferation, insulin secretion, and sensitivity and energy expenditure (Lee et al., 2007) . A second gene expressed in osteoblasts, Esp, inhibits endocrine functions of osteocalcin by favoring, through an indirect mechanism, its carboxylation (Ferron et al., 2010; Fulzele et al., 2010) . Despite these findings, basic facts about how osteocalcin performs its endocrine function are unknown. Most importantly, the receptor for osteocalcin remains to be determined, as do the signaling pathways triggered by this hormone in target cells.
We now show that osteocalcin, in addition to its endocrine role as a regulator of energy homeostasis, favors male fertility. It does so by promoting synthesis by Leydig cells of testosterone, a steroid hormone that is required for many aspects of testicular function (Sinha Hikim and Swerdloff, 1999; Walker, 2009 ) and has no effect on female fertility. Furthermore, we identify a bona fide receptor for osteocalcin that is expressed and transduces its signal in Leydig cells. Using this tool, we identify genes whose expression is regulated by osteocalcin in these cells and that account for its regulation of male fertility. Our findings expand the biological importance of osteocalcin, begin to unravel its molecular mode of action, and provide the first evidence that the skeleton is an endocrine regulator of fertility.
RESULTS

Osteoblasts Enhance Testosterone Production by Leydig Cells
In an effort to determine whether osteoblasts or any other cells of mesenchymal origin may regulate the functions of gonads, we asked whether supernatants of mesenchymal cell cultures affect hormone production by testes and/or ovaries ( Figure 1A) . In a first set of exploratory experiments, we observed that, of all those tested, the supernatant of osteoblast cultures increased testosterone secretion by testes explants to the largest extent (>3-fold) but did not affect estradiol and progesterone secretion by testes or ovaries ( Figures 1B-1G ). In subsequent experiments, testes explants were replaced by defined cell populations. Because testosterone is produced by Leydig cells, we asked whether osteoblast-derived molecule(s) act(s) directly on Leydig cells by culturing mouse primary Leydig cells in the presence or absence of supernatants of osteoblast cultures or of other mesenchymal cell type cultures. In the conditions of this assay, supernatants of osteoblast cultures were also the only ones that were able to significantly increase testosterone production by Leydig cells (>4-fold) ( Figure 1H ). These experiments indicate that osteoblasts are the cells of mesenchymal origin that affect testosterone biosynthesis to the largest extent and that they do so through secreted molecule(s) acting on Leydig cells of the testis. This endocrine function of osteoblasts was restricted to androgen production.
Osteocalcin Favors Male Fertility by Enhancing Testosterone Production
Osteocalcin is a major osteoblast-derived hormone. We had previously noticed that Osteocalcin-deficient male mice (Ocn À/À ) breed poorly (P.D. and G.K., unpublished data), so we tested whether it could be a, or the, osteoblast-derived hormone enhancing testosterone secretion by Leydig cells.
Several lines of evidence indicated that that is the case. First, supernatants of wild-type (WT), but not of Ocn À/À , osteoblast cultures increased testosterone production by Leydig cells (Figure 2A) . Second, treating Leydig cells with an increasing amount of uncarboxylated osteocalcin, the active form of the hormone, resulted in a dose-dependent increase in testosterone secretion, although at high concentration, the stimulatory effect of osteocalcin weakened ( Figure 2B ). Third, injection of osteocalcin in WT mice increased circulating levels of testosterone ( Figure 2C ). Fourth, we analyzed loss-(Ocn À/À mice) and gain-of-function (Esp À/À mice) mouse models for osteocalcin (Lee et al., 2007) .
When Ocn À/À males were crossed with WT female mice, the size of the litters was nearly 2-fold smaller than when WT males were crossed with WT females ( Figure 2D ). Conversely, the number of pups per litter was increased when Esp À/À males were bred with WT female mice, although this increase did not reach statistical significance ( Figure 2D ). The frequency of litters for a period of 8 weeks was also decreased in the case of the loss-of-function model and increased in the gain-of-function model ( Figure 2E ). Testes size and weight were significantly decreased in Ocn À/À and increased in Esp À/À mice at 3 months of age. In some of the latter mutant mice, this was caused, in part, by fluid accumulation (Figures 2F and 2G ). Figure 2K ). Accordingly, circulating levels of luteinizing hormone (LH), a pituitary-derived hormone favoring testosterone synthesis, was increased 2.5-fold in Ocn À/À mice ( Figure 2L ). Taken together, these cell biological and genetic experiments identify osteocalcin as a secreted molecule favoring male fertility by increasing testosterone production by Leydig cells. Circulating progesterone levels were similar in Ocn À/À and WT mice, and although circulating levels of estradiol were higher in Ocn À/À than in WT mice, they remained within the normal range (from 9.3 to 28.9 ng/ml for nonbreeder mice and from 14.4 to 71.1 ng/ml for breeder mice) ( Figure 2K ). Estradiol levels were not affected in Esp À/À mice. As predicted by the coculture assays, female fertility, ovary weight, morphology of the uterus, follicles number, and circulating levels of sex steroid hormones were normal in Ocn À/À female mice (Figures S1D-S1L).
Osteocalcin Regulates Male Fertility as an Osteoblast-Derived Hormone
To verify that osteocalcin regulates male fertility as an osteoblast-secreted hormone and not as a testis-secreted factor, we performed gene expression and cell-specific gene deletion experiments. When assessing Osteocalcin expression by quantitative PCR (qPCR), we observed that it was more than 750-fold higher in bone than in gonads; accordingly, we failed to detect Osteocalcin transcript or protein in testes by in situ hybridization or western blot analyses ( Figures 3A-3C ). To be able to trace Osteocalcin-expressing cells in vivo, we knocked the mCherry fluorescent reporter gene into the Ocn locus (Ocn-mCherry mice) ( Figures S2A and S2B ). Though we observed the expected strong signal in osteoblasts, there was no detectable mCherry fluorescence in testes ( Figure 3D ). Thus, in multiple assays, we failed to detect Osteocalcin expression in testes.
Next, we generated cell-specific loss-and gain-of-function models of osteocalcin by crossing mice harboring floxed alleles of Ocn (Figures S2C and S2D) or Esp with either the a1(I) Collagen-Cre transgenic mice or the Cyp17-iCre transgenic mice to delete genes in osteoblasts or in Leydig cells only, respectively (Bridges et al., 2008; Dacquin et al., 2002) . Testes size and weight, epididymides and seminal vesicles weights, sperm count, and circulating testosterone levels were all (L) Circulating LH levels in Ocn À/À compared to WT nonbreeder littermate mice.
Error bars represent SEM. Student's t test; *p < 0.05; **p < 0.001. See also Figure S1 .
consequence on testis biology, demonstrating that it is through its expression in osteoblasts, not in Sertoli cells, that Esp regulates male fertility ( Figures 3K-3N ). These experiments therefore indicate that it is only through its expression in osteoblasts that osteocalcin promotes male fertility.
Cellular and Molecular Bases of Osteocalcin Regulation of Male Fertility
To address this aspect of osteocalcin biology, we first studied the morphology of Leydig cells by immunostaining of 3-b-hydroxysteroid dehydrogenase (3b-HSD). The number of Leydig cells was not significantly affected by the absence of osteocalcin or Esp, nor was the expression of genes affecting cell proliferation ( Figure 4A and data not shown When germ cells were analyzed through a stereological approach, we observed that the number of spermatocytes and Error bars represent SEM. Student's t test; *p < 0.05; **p < 0.001. See also Figure S2 .
round spermatids was significantly decreased in Ocn À/À mice ( Figure 4D ). Consistently, the size of the epithelium in testis tubules was also significantly decreased in these mutant mice, a feature suggesting that osteocalcin regulates, presumably through its effect on testosterone biosynthesis, germ cell number ( Figure S3B ). Because testosterone inhibits germ cell apoptosis (Brinkworth et al., 1995; Henriksé n et al., 1995; Sinha Hikim and Swerdloff, 1999) , we performed TUNEL assays. Those showed a 2-fold increase in germ cell apoptosis in Ocn À/À compared to WT mice and a 2-fold decrease in Esp À/À testes ( Figure 4F ). Importantly, there was an increase in the number of apoptotic cells in stages VI-VIII of the spermatogenic cycle, the very stages of spermatogenesis in which testosterone affects germ cell apoptosis more efficiently (Sharpe et al., 1992) ( Figure S3C ). There were, on the other hand, no abnormalities of germ cell proliferation in either Ocn Error bars represent SEM. Student's t test; *p < 0.05; **p < 0.001. See also Figure S3 .
( Figure S3A ). Taken together, these data further indicate that the decrease in fertility demonstrated by Ocn À/À male mice is caused by a decrease in testosterone levels. To determine how osteocalcin favors testosterone synthesis by Leydig cells, we tested whether it affects expression of the enzymes that are necessary for testosterone biosynthesis such as StAR, Cyp11a, Cyp17, and 3b-HSD. In cell culture, uncarboxylated osteocalcin increased expression of these genes in Leydig cells ( Figure 4F) Figures 4F-4H ).
To further support the notion that osteocalcin influences germ cell apoptosis through testosterone, we examined expression of Gonadotropin Regulated Testicular Helicase (Grth) because this gene has emerged as an essential regulator of spermatogenesis that inhibits germ cell apoptosis and whose expression in germ cells and Leydig cells is regulated by testosterone Tsai-Morris et al., 2007 . Grth expression was decreased in Ocn À/À and increased in Esp À/À testes ( Figure 4I ). GRTH inhibits activation of caspase 3, a determinant of apoptosis (Sheng et al., 2006) , and favors expression of tACE, a protein favoring germ cell maturation. Consistent with these notions, western blot analyses showed an increase of cleaved caspase 3 accumulation and a decrease of tACE in Ocn À/À testes ( Figure 4J ).
Gprc6a, a G Protein-Coupled Receptor, Transduces Osteocalcin Signal in Leydig Cells
To begin to elucidate the molecular mode of action of osteocalcin, we next searched for a receptor expressed in Leydig cells that could transduce its signal. To that end, we used a twostep experimental strategy, taking advantage of the fact that osteocalcin regulates fertility only in male mice. First, we defined the signal transduction pathway used by osteocalcin (these experiments were performed in TM3 cells, and not primary Leydig cells, in order to obtain a sufficient amount of extract for analysis). With this aim, we treated the cells with uncarboxylated osteocalcin and assayed for tyrosine phosphorylation, ERK activation, intracellular calcium accumulation, and cAMP production, using in each case an appropriate positive control. Osteocalcin consistently induced cAMP production in Leydig cells to a level comparable to that induced by human chorionic gonadotropin, the positive control, but did not induce tyrosine phosphorylation, ERK activation, or intracellular calcium accumulation in these cells (Figures 5A-5D ). At higher concentrations, osteocalcin stimulation of cAMP production weakened. These data implied that the osteocalcin receptor may be a G protein-coupled receptor (GPCR). Hence, in the second step of this experimental strategy, we took advantage of the dichotomy of function of osteocalcin between males and females and asked how many orphan GPCRs were expressed in testes at a level at least 5-fold higher than in ovary. Twenty-two out of 103 orphan GPCRs tested were predominantly expressed in testes; of these 22, four were enriched in Leydig cells (Figures 5E and 5F ). Among them, Gprc6a caught our attention because its deletion in all cells results in a metabolic and fertility phenotype similar to that of Ocn À/À mice (Pi et al., 2008) .
Immunofluorescence experiments verified that Gprc6a is expressed in Leydig cells in testes, but not in follicular cells of the ovary. Importantly, the same is true in human gonads ( Figures 5G and 5H and Figure S4B ). Postnatally, Gprc6a expression peaked within the first week of life, when circulating testosterone levels are elevated. Gprc6a expression then decreased before increasing again at 6 weeks of age, when circulating levels of testosterone also rebound ( Figure 5I ). We also performed binding assays on mouse testes using biotinylated osteocalcin as a ligand. In the conditions of this assay, osteocalcin bound to Leydig cells and the specificity of this binding was confirmed by several criteria. First, there was no signal when using avidin-biotin alone; second, there was no signal either in other cellular compartments of the testicular tubules; third, we could not detect any binding when using Gprc6a-deficient testes; fourth, osteocalcin binding could be competed away by an excess (100-fold) of unlabeled osteocalcin, but not by the same excess of hCG or of other molecules proposed as ligands of Gprc6a (Wellendorph et al., 2005) (Figure 5J ). These data identify Gprc6a as an osteocalcin receptor in Leydig cells.
To define Gprc6a function in Leydig cells in vivo, we generated Gprc6a Leydig À/À mice. Prior to analyzing these Gprc6a Leydig
mice, we verified that we had deleted Gprc6a, albeit partially (75% of deletion), in Leydig cells, but not in other organs ( Figures  S5C and S5D ). In Gprc6a Leydig À/À male mice, testes size and weight, epididymis and seminal vesicle weights, sperm counts and circulating testosterone levels, and Leydig cell area were all reduced, as was the expression of Grth and the three genes controlling testosterone biosynthesis that are regulated by osteocalcin ( Figures 6A-6I and Figure S5E ). Accordingly, the number of apoptotic germ cells was increased compared to WT testes ( Figure 6J ). Figures 6A-6I ).
CREB Is a Transcriptional Effector of Osteocalcin Signaling in Leydig Cells
Observations that osteocalcin treatment of Leydig cells increased cAMP production and that the osteocalcin receptor is a GPCR suggested that CREB could mediate osteocalcin functions in these cells. In support of this hypothesis, osteocalcin treatment of Leydig cells favors CREB phosphorylation (Figure 7A ). To investigate this further, we generated mice that lack CREB expression specifically in Leydig cells (Creb Leydig À/À mice). Twelve-week-old Creb Leydig À/À male mice displayed a reduction in testis size and weight, in epididymides and seminal vesicles weights, in sperm count, and in circulating testosterone levels similar to those seen in Ocn À/À and Gprc6a Leydig À/À mice ( Figures 7B-7G and Figure S6 ). Creb Leydig À/À mice also demonstrated a strong decrease in the expression of Grth and of the four genes involved in testosterone biosynthesis whose expression is regulated by osteocalcin ( Figures 7H and 7I ). In agreement with these data, CREB could bind to the promoter regions of Cyp11a, 3b-HSD, and StAR (Zhang et al., 2005) (Figure 7J ). To establish whether CREB acts downstream of Gprc6a in Leydig cells to regulate male fertility, we generated compound heterozygous mice lacking one copy of Creb and one copy of 
DISCUSSION
This study reveals that bone is a positive regulator of male fertility. This interaction is mediated through the osteoblastderived hormone osteocalcin, which binds to a specific receptor that is present on Leydig cells of the testes and favors testosterone biosynthesis ( Figure 7K ). Our results, along with those previously published, support the hypothesis that regulation of bone remodeling, energy metabolism, and reproduction are linked (Ducy et al., 2000; Lee et al., 2007) . They also demonstrate that bone is a more important regulator of whole-organism physiology than was anticipated. In the last 10 years, the view of bone as a mere assembly of inert calcified tubes has evolved because two independent lines of investigation painted a much more dynamic picture of this tissue. First, the dialog between bone physiology and energy metabolism and the paramount influence of the brain in the control of bone mass accrual became apparent (Karsenty, 2006) . Second, it has been realized that bone is an endocrine organ regulating at least two functions, phosphate metabolism and energy homeostasis, through two distinct osteoblastderived hormones, FGF23 and osteocalcin (Fukumoto and Yamashita, 2007; Lee et al., 2007) . These two endocrine functions of bone begged the following question: are these the only functions affected by bone in its endocrine capacity?
The well-known regulation of bone remodeling by gonads provides an ideal setting to address this question and raises the possibility that bone, in its endocrine capacity, could influence through a feedback mechanism reproductive functions in either gender. We show here that osteoblasts, the bone-forming cells, favor through osteocalcin fertility in male, but not female, mice. Our observation that Ocn À/À mice have low circulating testosterone levels despite an increase in circulating LH levels may have several explanations. For instance, it could be that deletion of osteocalcin causes, for unknown reasons, a loss of negative feedback. Alternatively, it may also suggest that LH cannot favor testosterone production in the absence of osteocalcin. Further experiments will be required to address this point. All of our experiments conducted ex vivo and in vivo in lossand gain-of-function models indicate that the main mechanism whereby osteocalcin favors male fertility is by increasing testosterone synthesis in Leydig cells. Testosterone, in turn, supports maturation and prevents apoptosis of germ cells (Henriksé n et al., 1995; Sinha Hikim and Swerdloff, 1999; Walker, 2009 (Bremner et al., 1994; De Gendt et al., 2004; Wang et al., 2003) . Unexpectedly, Ocn À/À male mice have a higher level of circulating estrogen than WT littermates, even though osteocalcin does not promote estradiol synthesis. The most likely explanation for this mild increase in circulating estradiol levels in the Ocn À/À mice is that the increase in the number of adipocytes caused by Osteocalcin inactivation may result in an increase in the aromatization of testosterone into estrogen in fat (Nelson and Bulun, 2001; Simpson et al., 2000; Simpson, 2003) . Importantly, this was also observed in mice lacking Gprc6a (Pi et al., 2008) .
The existence of such a profound influence exerted by a hormone other than LH on sex steroid hormone synthesis raises the question of whether it is a male-specific phenomenon. To date, we have no evidence that, at least in the mouse, the skeleton favors estrogen production in females. This, however, does not rule out the possibility that other peripheral organs may secrete hormones favoring estrogen synthesis.
The growing number of functions identified for osteocalcin makes the identification of its receptor all the more important. An unbiased approach based on the ability of osteocalcin to increase cAMP production in Leydig cells and on its dichotomy of function between male and female gonads led to the identification of Gprc6a as the osteocalcin receptor. This orphan receptor, which belongs to the C family of GPCRs (Wellendorph and Brä uner-Osborne, 2004) , has been proposed to be a receptor for amino acids, for calcium in the presence of osteocalcin as a cofactor, and for androgen (Pi et al., 2005 (Pi et al., , 2008 (Pi et al., , 2010 ). Yet, the possibility that Gprc6a could be a specific receptor for osteocalcin has never been tested through biochemical or genetic means. Here, we provide biochemical and genetic evidence establishing its identity as a specific receptor for osteocalcin in Leydig cells, though we failed to detect an interaction between amino acids and Gprc6a. That Gprc6a is expressed in human and mice Leydig cells in the testes, but not in follicular cells of ovaries, provides a molecular basis for the fact that osteocalcin affects male fertility only. The expression of this receptor is extremely dynamic and peaks at adulthood when testosterone biosynthesis is at its maximum (Feldman et al., 2002; Gray et al., 1991; Quigley, 2002) . This observation suggests that the regulation of osteocalcin functions occurs, at least in part, by regulating the expression of its receptor. The identification of an osteocalcin receptor opens the door to a thorough molecular dissection of the mode of action of osteocalcin in various cell types where it is expressed. This may eventually lead to the identification of additional functions for osteocalcin.
An obvious question raised by this study is whether the skeleton also regulates male fertility in humans. In the absence of inactivating mutations in the Osteocalcin or Gprc6a genes in humans and of studies correlating circulating levels of uncarboxylated osteocalcin and fertility in the aging male population, this question can only be addressed through indirect means for now. Although we cannot rule out the possibility that the endocrinology of reproduction may be different in this particular aspect between rodents and humans, indirect evidence suggests that the function of osteocalcin described here may be conserved in humans. First, and most importantly, this work was, in part, initiated because of a clinical observation made in humans: loss of sex steroid hormones triggers a decrease in bone mass. This led us to test whether feedback regulation of fertility by bone may also occur. Second, Gprc6a is expressed, in human and in mice, in Leydig cells of the testes, but not in ovaries. Hence, the entire signaling cascade from the hormone to the receptor exists in the equivalent organs in humans. Third, the growing number of reports indicating that osteocalcin is a reliable indicator of glucose intolerance, just as it is in mice, strongly suggests that this molecule also acts as a hormone in humans (Kanazawa et al., 2010; Saleem et al., 2010; Yeap et al., 2010) . Along these lines, there is no example yet of a molecule being a hormone in the mouse that has abruptly lost this attribute in humans. This is, nevertheless, an aspect of osteocalcin that will need further investigation in the future.
EXPERIMENTAL PROCEDURES Mice Generation
All experiments were performed on the 129-Sv (Taconic) genetic background. Control littermates were used in all experiments. Mice genotypes were determined by PCR; primer sequences are available upon request. OsteocalcinmCherry knockin, Ocn conditional, and Gprc6a conditional allele generation strategies are described in Figure S2 and Figure S5 .
Primary Leydig Cells and Testes Explant Preparation
Adult mouse Leydig cells were isolated by mechanical dissociation of the testes followed by purification on a 0%-90% Percoll gradient (Hunter et al., 1982; Schumacher et al., 1978) . Primary Leydig cells were cultured in Minimal Essential Medium (MEM + GlutaMAX, Invitrogen) supplemented with 1 3 PenStrep, 25 mM HEPES (pH 7.4), and 0.07% BSA at 33 C in 5% CO 2 . After 3 hr of attaching and starvation, cells were washed once with culture medium and then used for experiments. The testes explant preparation protocol was adapted from (Powlin et al., 1998) . Explants were washed three times with PBS and placed in serum-free RPMI medium for 2 hr before being used for experiments.
Osteocalcin Stimulation of Leydig Cells or Testes Explants
Primary Leydig cells and testes explants were washed three times with PBS and stimulated with different doses of recombinant osteocalcin prepared as previously described (Ferron et al., 2008) or with hCG as a positive control. After 1 hr, an aliquot of medium was collected for measurements of testosterone. Cells were then maintained for 3 additional hr and lysed in 1 ml TRIZOL (Invitrogen) for RNA isolation.
Sperm Counts and Hormone Measurements
Caudal epididymides were minced in 1 ml PBS, and the number of cells released was counted after 1 hr. The total sperm count was assessed in the final suspension by using a hemocytometer (Dakhova et al., 2009) . Circulating levels of testosterone, estradiol (E2), and progesterone were measured by radioimmunoassay (RIA) from Diagnostic Systems Laboratories (Testosterone RIA DSL-4000, Estradiol RIA DSL-43100, and Progesterone RIA-3900).
Histology
One testis or ovary from each mouse was randomly selected for molecular analysis, and the other one was used for histology. Specimens were collected, weighed, and fixed in Bouin's fixative for histological analyses before being dehydrated through graded ethanol, processed for paraffin embedding, and serially sectioned at 5 mm. For histological analysis, testes and ovaries sections were stained with periodic acid-Schiff and counterstained with hematoxylin. TUNEL labeling was performed using the ApopTag Peroxydase In Situ Apoptosis detection kit (Millipore-S7100). Apoptotic indices were determined by counting the total number of TUNEL-positive cells or the number of TUNELpositive germ cells at different stages (Russell et al., 1990) . Approximately 500 tubules were counted on at least four cross-sections located at midtestis for each animal.
Gene Expression Studies RNA was purified from tissues, primary Leydig cells, or cultured cells using TRIZOL (Invitrogen). RNA isolation, cDNA preparation, and qPCR analysis was carried out following standard protocols. qPCR analyses were performed using specific quantitative PCR primers from SABiosciences (http://www. sabiosciences.com/RT2PCR.php). 
Receptor Binding Assays
For binding studies, testes from 8-week-old mice were snap-frozen in liquid nitrogen, and 20 mm thick sections were prepared and desiccated overnight at 4 C under vacuum. On the following day, sections were rehydrated in icecold binding buffer (50 mM TrisHCl [pH 7.4], 10 mM MgCl 2 , 0.1 mM EDTA, and 0.1% BSA) for 15 min and incubated for 1 hr in the presence of biotinylated osteocalcin. For competition assays, a 100-fold molar excess of unlabeled osteocalcin, glycine, lysine, or hCG was added. After three washes in cold PBS, sections were incubated for 1 hr in the detection system containing 0.1% BSA (ABC Elite, Vector Laboratories), washed again, and incubated with DAB peroxidase substrate kit (Vector Laboratories) according to the manufacturer's protocol. After a final wash, sections were mounted in waterbased mounting medium. As negative controls, we used sections incubated with the detection system only (ABC Elite and DAB) or Gprc6a À/À testis sections (Basura et al., 2008) . 
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